Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 4 Breast Neoplasms 3 Recurrence 2 Paraproteinemias 2 Papillomavirus Infections 2 Immunoglobulin Light-chain Amyloidosis 2 Colorectal Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Postoperative Complications 1 Pneumonia 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Obesity 1 Neoplasms, Plasma Cell 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Locally Advanced Breast Cancer 1 Intermittent Fasting 1 Hypothyroidism 1

Interventions

Ifosfamide 30 Methotrexate 29 Doxorubicin 26 Cyclophosphamide 24 Cisplatin 22 Filgrastim 18 Etoposide 17 Gemcitabine 16 Leucovorin 14 Magnetic Resonance Spectroscopy 11 Temozolomide 10 Specimen Handling 10 cabozantinib 9 apatinib 9 X-Rays 9 Carboplatin 9 fludarabine 8 Radiotherapy 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Drug Therapy 8 Docetaxel 8 Zoledronic Acid 7 Vincristine 7 Sirolimus 7 Phantoms, Imaging 7 Biopsy 7 mifamurtide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Clinical Protocols × Clear all

NCT04132895 2024-08-02

ICONIC

University College, London

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡